Four divisions, one Grifols
Grifols has four business divisions united by a shared commitment to quality, safety, and ongoing innovation: Bioscience, Diagnostic, Hospital, and Bio Supplies.
Our consolidated and complementary core business units develop, produce, and market innovative products and services in over 100 countries or regions.
Leading producer of plasma-derived medicines for the treatment of rare, chronic, and sometimes life-threatening conditions.
Advancing patient care with diagnostic solutions that improve disease detection and management and simplify laboratory operations.
Serving the needs of hospital pharmacies to contribute to safe, high-quality healthcare for patients worldwide.
As a result of continuous innovation since the foundation of Grifols in 1909, today our manufacturing facilities set industry standards.
Our facilities are designed and built by Grifols Engineering, drawing on the experience acquired in the development of machinery, equipment, and complex manufacturing facilities for the pharmaceutical industry.
This unit also offers its engineering services to the biotechnology sector.
We have 16 industrial state-of-the-art facilities in seven countries that provide us with the capacity and flexibility to satisfy a growing demand for our products.
The Bioscience Division carries out the fractionation and purification processes in its manufacturing plants in the US (Clayton, North Carolina and Los Angeles, California), Canada (Montreal), Ireland (Dublin), and Spain (Barcelona). At present, the company has a fractionation capacity of 15.2 million liters of plasma per year. Five Grifols-owned testing laboratories, three in the U.S. (Austin and San Marcos, Texas, and Memphis, Tennessee), one in Germany (Berlin), and another one in Spain (Barcelona).
The Diagnostic Division has production centers in the US (Emeryville and San Diego, California), Spain (Barcelona, Vizcaya and Murcia), Switzerland (Düdingen), Australia (Melbourne), and Brazil (Campo Largo).
The Hospital Division carries out its production in Spain (Barcelona, San Sebastián and Murcia), and in the US (Denver, Colorado).
The Bio Supplies Division has production centers in Germany (Leipzig), and in the US (Memphis, Tennessee).
Products and services
How can we help you?
Grifols R+D+i projects focus on broadening the therapeutic potential of plasma proteins, enhancing the safety of blood transfusions, creating new solutions for hospital pharmacies, and advancing intravenous therapies.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos in Barcelona.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?